Literature DB >> 11779429

Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3.

P Jia1, G Chen, X Huang, X Cai, J Yang, L Wang, Y Zhou, Y Shen, L Zhou, Y Yu, S Chen, X Zhang, Z Wang.   

Abstract

OBJECTIVE: To investigate the response of multiple myeloma (MM) cells to arsenic trioxide (As2O3) and their possible mechanisms.
METHODS: Two MM-derived cell lines RPMI8226 and U266 cells were used as in vitro models. Cell apoptosis was assessed by morphology, flow cytometry, and DNA gel electrophoresis. Mitochondrial transmembrane potentials (delta psi m) were evaluated by measuring cellular Rhodamine 123 staining intensity. Protein expression was analyzed using Western blot.
RESULTS: Zero point one to 0.5 mumol/L As2O3 inhibited cell proliferation and 2.0 mumol/L As2O3 induced cell apoptosis, while 1.0 mumol/L As2O3 inhibited proliferation with a weak degree of apoptosis induction in RPMI8226 and U266 cell lines. As2O3-induced apoptosis was accompanied by mitochondrial transmembrane potentials (delta psi m) collapse and caspase-3 activation in the presence of intact membrane. Glutathione depleter buthionine sulfoximine enhanced, while disulfide bond-reducing agent dithiothreitol partially antagonized As2O3-induced delta psi m collapse and apoptosis in MM cells. All-trans retinoic acid (ATRA) could also induce apoptosis in RPMI8226 cells, but it did not show any cooperative effects with As2O3.
CONCLUSION: As2O3 exerts apoptosis-inducing and growth-inhibiting effects on MM cells, and mitochondrium is a pivotal and common target of As2O3 for apoptosis induction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11779429

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  12 in total

1.  In-vitro cytotoxic and genotoxic effects of arsenic trioxide on human leukemia (HL-60) cells using the MTT and alkaline single cell gel electrophoresis (Comet) assays.

Authors:  Clement G Yedjou; Paul B Tchounwou
Journal:  Mol Cell Biochem       Date:  2007-01-10       Impact factor: 3.396

2.  OXIDATIVE STRESS IN HUMAN LEUKEMIA (HL-60), HUMAN LIVER CARCINOMA (HepG2), AND HUMAN (JURKAT-T) CELLS EXPOSED TO ARSENIC TRIOXIDE.

Authors:  Clement G Yedjou; Paul B Tchounwou
Journal:  Met Ions Biol Med       Date:  2006

3.  Cytotoxicity and oxidative stress in human liver carcinoma cells exposed to arsenic trioxide (HepG(2)).

Authors:  Erika Brown; Clement G Yedjou; Paul B Tchounwou
Journal:  Met Ions Biol Med       Date:  2008

4.  GENOTOXIC MECHANISMS OF ARSENIC TRIOXIDE IN HUMAN JURKAT T-LYMPHOMA CELLS.

Authors:  Clement Yedjou; La'mont Sutton; Paul Tchounwou
Journal:  Met Ions Biol Med       Date:  2008

5.  Cell cycle arrest and apoptotic cell death in cultured human gastric carcinoma cells mediated by arsenic trioxide.

Authors:  Qin-Shu Shao; Zai-Yuan Ye; Zhi-Qiang Ling; Jin-Jing Ke
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

6.  BH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide-induced cell death in myeloma.

Authors:  Alejo A Morales; Delia Gutman; Kelvin P Lee; Lawrence H Boise
Journal:  Blood       Date:  2008-03-19       Impact factor: 22.113

7.  Gene expression profile of multiple myeloma cell line treated by arsenic trioxide.

Authors:  Mengchang Wang; Shaanxi Liu; Pengbo Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-12

Review 8.  Glutathione-coordinated metal complexes as substrates for cellular transporters.

Authors:  Stephen A Pearson; J A Cowan
Journal:  Metallomics       Date:  2021-04-30       Impact factor: 4.526

9.  Dose- and time-dependent response of human leukemia (HL-60) cells to arsenic trioxide treatment.

Authors:  Clement G Yedjou; Pamela Moore; Paul B Tchounwou
Journal:  Int J Environ Res Public Health       Date:  2006-06       Impact factor: 3.390

10.  Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells.

Authors:  Sanjay Kumar; Clement G Yedjou; Paul B Tchounwou
Journal:  J Exp Clin Cancer Res       Date:  2014-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.